Biomarkers Commercialization: Diagnostics & Drug Development
- Evaluating the role of commercial diagnostic strategy in supporting launch of companion diagnostics
- Developing optimal strategies for test implementation and adoption at launch
- Assessing the direct impact of suboptimal tests on patient outcomes